topiramate
Selected indexed studies
- Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations. (Adv Ther, 2023) [PMID:37368102]
- Phentermine/Topiramate: Pediatric First Approval. (Paediatr Drugs, 2022) [PMID:36059008]
- Topiramate for juvenile myoclonic epilepsy. (Cochrane Database Syst Rev, 2019) [PMID:30687937]
_Worker-drafted node — pending editorial review._
Connections
topiramate is a side effect of
Sources
- Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations. (2023) pubmed
- Phentermine/Topiramate: Pediatric First Approval. (2022) pubmed
- Topiramate for juvenile myoclonic epilepsy. (2019) pubmed
- Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial. (2024) pubmed
- Topiramate for Weight Management in Children With Severe Obesity. (2023) pubmed
- Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial. (2024) pubmed
- Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review. (2019) pubmed
- Mechanisms of neurodevelopmental toxicity of topiramate. (2024) pubmed
- Advances in topiramate as prophylactic treatment for migraine. (2021) pubmed
- Topiramate monotherapy for juvenile myoclonic epilepsy. (2017) pubmed